Parag Gad

Parag Gad is the Co-Founder and CEO of SpineX Inc., a company focused on developing innovative therapies for neurological conditions.4 With over 15 years of experience in preclinical and clinical research and product development, Gad has established himself as a leader in the field of spinal neuromodulation.1

Professional Background

Parag Gad's expertise lies in developing cutting-edge treatments for neurological disorders, particularly those affecting the spinal cord. His work at SpineX has led to the development of several notable therapies:

SCONE Therapy:: A novel treatment for neurogenic bladder, which was showcased at the SUFU 2023 meeting in Nashville.2

Non-invasive Spinal Neuromodulation:: Gad has been involved in research and development of non-invasive spinal neuromodulation techniques for treating spinal cord injuries.5

Recent Achievements

Parag Gad has been actively involved in various aspects of SpineX's growth and development:

• As of August 2024, one of the products Gad developed was featured in a prominent setting, marking a significant milestone in his career.3
• In August 2024, he announced a new publication related to non-invasive spinal neuromodulation and spinal cord injury research.5
• By December 2023, SpineX was nearing full recruitment for a clinical trial of their SCONE therapy.7

Ongoing Work

Gad continues to lead SpineX in its mission to advance spinal neuromodulation therapies. He regularly shares updates on LinkedIn about the company's progress, new publications, and advancements in the field of spinal cord injury treatment.68